Viewing Study NCT00605020


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-02-27 @ 3:45 PM
Study NCT ID: NCT00605020
Status: COMPLETED
Last Update Posted: 2017-06-27
First Post: 2008-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
Keywords: